1. Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Overview
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analysis
4. Market Dynamics
4.1 Drivers
4.1.1 Ease of Drug Delivery
4.1.2 High Prevalence of Skin Diseases
4.2 Restraints
4.2.1 High Frequency of Product Recalls
4.2.2 Stringent Approval Process
4.3 Opportunities
4.3.1 Power of Suppliers
4.3.2 Power of Consumers
4.4 Challenges
4.4.1 Providing Suitable Medicine
5. Europe Topical Drug Delivery Market - By Product
5.1 Formulation
5.1.1 Liquid
5.1.1.1 Solution
5.1.1.2 Suspension
5.1.2 Semi-Solid
5.1.2.1 Ointment
5.1.2.2 Gel
5.1.2.3 Paste
5.1.2.4 Cream & Lotion
5.1.3 Solid
5.1.3.1 Powder
5.2 Device
5.2.1 Patch
5.2.2 Inhaler
5.2.3 Transdermal Drug Delivery
6. Europe Topical Drug Delivery Market - By Administration
6.1 Vaginal
6.2 Oral topical
6.3 Ophthalmic
6.4 Nasal
6.5 Dermal
6.6 Skin
6.7 Others
7. Europe Topical Drug Delivery Market - By Facility of Use
7.1 Hospitals
7.2 Private Clinics
7.3 Home Care Settings
7.4 Others
8. Europe Topical Drug Delivery Market – By Country
8.1 Introduction
8.2 North America
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.2.4 Rest of North America
9. Europe Topical Drug Delivery Market – By Company Profiles
9.1 Glaxosmithkline
9.2 Galderma
9.3 Valeant Pharmaceuticals
9.4 Hisamitsu Pharmaceuticals
9.5 Bayer
9.6 Becton, Dickinson and Company
9.7 Merck & Co., INC
9.8 Innocore pharmaceuticals
9.9 Bioportfolio
9.10 Mylan Pharmaceutical Company
9.11 Jubilant Hollisterstier
9.12 Johnson & Johnson Services., INC
9.13 CPHL
9.14 Labvantage Solutions
9.15 BiopharmX
10. Europe Topological Drug Delivery Market – By Competitive Landscape
10.1. Market Share Analysis
10.2. Strategies Adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
11. Market Insights
11.1 Insights of Industry Experts
11.2 Analyst Opinion (Market Understanding)
11.3 Investment Opportunities
12. Appendix
12.1 List of Tables
12.2 List of Figures
